GLP-1 Agonists: Seven Indications, One Drug-Class, Zero Access,
Starting on:
Mar 12, 2026
Ending on:
Mar 23, 2026
Moderator(s):
Dr. George Otieno
KCS
Venue:
https://medicallearninghub.africa/registration/d41cf4e9-97c2-4df8-953a-b56633a9d3f8?org-id=efce1096-3e62-4bb2-8ac1-16448f14e03e
Max Credits:
3 Points

Provider:
Kenya Cardiac Society
Claim Points

GLP-1 Agonists: Seven Indications, One Drug-Class, Zero Access,

Starting on:
Mar 12, 2026
Ending on:
Mar 23, 2026
Venue:
https://medicallearninghub.africa/registration/d41cf4e9-97c2-4df8-953a-b56633a9d3f8?org-id=efce1096-3e62-4bb2-8ac1-16448f14e03e

Description

webinar focuses on GLP-1 Agonists: Seven Indications, One Drug-Class, Zero Access, highlighting the expanding clinical applications of GLP-1 receptor agonists in cardiovascular and metabolic care, while addressing challenges in access and affordability in clinical practice.

Objectives

Outline the key clinical indications for GLP-1 receptor agonists. Understand their cardiovascular and metabolic benefits. Identify barriers to access and strategies to optimize patient care

Presenters

  1. Dr. Anders Barasa
    KCS
    KCS

Search For CPD Activity